Jingrong Jean Cui, Director at Turning Point Therapeutics, Inc. (TPTX), sold 52,399 shares at $42.42 ($2.1M) on 2020-03-10, disclosed to the SEC on 2020-03-12.
Open-market sale of $2.1M TPTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.61 | 7,100 | $295K | 13.9% |
| 2 | $42.42 | 8,000 | $339K | 16.0% |
| 3 | $43.33 | 3,400 | $147K | 6.9% |
| 4 | $40.02 | 4,700 | $188K | 8.9% |
| 5 | $40.02 | 4,700 | $188K | 8.9% |
| 6 | $40.61 | 6,800 |
| $276K |
| 13.0% |
| 7 | $41.50 | 2,400 | $100K | 4.7% |
| 8 | $42.86 | 3,200 | $137K | 6.5% |
| 9 | $43.72 | 1,400 | $61K | 2.9% |
| 10 | $34.96 | 2,600 | $91K | 4.3% |
| 11 | $36.07 | 1,821 | $66K | 3.1% |
| 12 | $36.07 | 1,821 | $66K | 3.1% |
| 13 | $36.94 | 1,878 | $69K | 3.3% |
| 14 | $36.94 | 1,878 | $69K | 3.3% |
| 15 | $37.91 | 701 | $27K | 1.3% |
| Total | $40.46 avg | 52,399 | $2.1M | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |